← Open Payments lookup

AYAA OUZA: Open Payments

NPI 1922662501 · HAMTRAMCK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$714 in 32 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $714

Food & beverage: $714
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$263
ABBVIE INC.5$117
Neurocrine BioSciences, Inc.2$71
Supernus Pharmaceuticals, Inc.3$68
Axsome Therapeutics, Inc.2$54
Otsuka America Pharmaceutical, Inc.2$49
Alkermes, Inc.2$42
Takeda Pharmaceuticals U.S.A., Inc.2$36
Gilead Sciences, Inc.1$15

Products named: CAPLYTA, VRAYLAR, INGREZZA, Qelbree, Auvelity, REXULTI, ARISTADA, TRINTELLIX.

Industry payments across MI — which companies pay providers there.